RATE25: Victor Ciardelli and Rate Companies, the #2 retail lender in the country, celebrate 25 years of empowering homeownership with the Launch of Rate25
Founded in 2000 as a bold startup on Chicago's north side, Rate has grown into one of the nation's top retail mortgage lenders. Rate has spent the past 25 years differentiating itself in the marketplace with low, low prices, cutting-edge technology, unparalleled speed, as well as expert advice and service.
At the heart of Rate's success is a mission to Grow for Good and make a meaningful impact on its customers' overall wellbeing, both financial and personal. This commitment comes to life through two key pillars: the Rate Foundation, which supports families and communities in need, and the newly launched Rate Super App, which brings together all of Rate's financial offerings and personal wellness resources in one seamless experience.
'Reaching this milestone is a moment of reflection, pride, and deep gratitude,' said Victor Ciardelli, Founder and CEO of Rate Companies. 'Our success has always been rooted in relationships, those we build with our customers, our employees, our referral partners, and the communities we serve. I'm incredibly proud of how far we've come and even more excited for what lies ahead.'
Rate25 will take place the week of June 23rd, bringing employees together across the country to celebrate its journey and future direction. The campaign includes company-wide recognitions, meaningful experiences, and a digital timeline celebrating the people and milestones that have shaped Rate.
'Our team's relentless drive to imagine what's possible and then bring that to life has been the foundation of Rate's success,' added Ciardelli. 'Rate25 is about celebrating how far we've come, while renewing our commitment to where we're going and beyond. Rate is truly building the future of fintech and personal wellness, by putting people first, using technology to empower, and staying grounded in our mission to make a meaningful difference in every life we touch.'
About RateRate Companies is a leader in mortgage lending and digital financial services. Headquartered in Chicago, Rate has over 850 branches across all 50 states and Washington D.C. Since its launch in 2000, Rate has helped more than 2 million homeowners with home purchase loans and refinances. The company has cemented itself as an industry leader by introducing innovative technology, offering low rates, and delivering unparalleled customer service. Honors and awards include: Top 5 Mortgage Lender by Inside Mortgage Finance for 2024; Best Mortgage Lender for First-Time Homebuyers by NerdWallet for 2023; HousingWire's Tech100 award for the company's industry-leading FlashClose℠ digital mortgage platform in 2020, MyAccount in 2022, and Language Access Program in 2023; the most Scotsman Guide Top Originators for 11 consecutive years; Chicago Agent Magazine's Lender of the Year for seven consecutive years; and Chicago Tribune's Top Workplaces list for seven straight years. Visit rate.com for more information.
Media Contact:press@rate.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Healthcare Distribution Market Size to Hit USD 1,765.68 Billion in 2032
Burlingame, CA, July 03, 2025 (GLOBE NEWSWIRE) -- The global Healthcare Distribution Market is estimated to be valued at USD 1,120.67 Bn in 2025 and is expected to reach USD 1,765.68 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032. Rising healthcare costs, a surge in chronic and lifestyle-related diseases, the growth of online distribution channels, and the expansion of medical infrastructure are driving global demand for pharmaceutical and medical device distribution services. As countries invest more in healthcare to achieve universal coverage, the volume of healthcare products requiring efficient and reliable distribution continues to grow. Request Sample Report: Global Healthcare Distribution Market Key Takeaways According to Coherent Market Insights (CMI), the global healthcare distribution market size is estimated to reach USD 1,120.67 Bn in 2025 and grow at a CAGR of 6.7% during the forecast period, surpassing USD 1,765.68 Bn by 2032. By product type, pharmaceutical segment is expected to account for more than half of the global healthcare distribution market share in 2025. Based on end user, hospitals pharmacies segment is set to hold a prominent market share of over two-fifths in 2025. As per CMI's new healthcare distribution market analysis, North America is expected to maintain its dominance, accounting for more than two-fifths of the market share in 2025. Asia Pacific is projected to emerge as the most remunerative market for healthcare distribution companies during the forecast period. Rising Demand for Pharmaceuticals and Medical Devices Spurring Market Growth Coherent Market Insights' latest healthcare distribution market analysis provides insights into major factors driving market growth. One such prominent growth driver is the increasing demand for pharmaceuticals and medical devices. The global prevalence of chronic diseases like cancer and diabetes is increasing significantly. This surge in chronic conditions is fueling demand for a wide range of pharmaceuticals and medical devices, thereby boosting growth of the healthcare distribution market. Immediate Delivery Available | Buy This Premium Research Report: Regulatory Hurdles and Supply Chain Disruptions Restraining Market Growth The future healthcare distribution market outlook looks bright, owing to increasing incidence of chronic diseases and growing demand for pharmaceuticals and medical devices. However, regulatory challenges and supply chain disruptions are expected to limit market growth to some extent. Introduction of stringent regulations by regulatory bodies like the FDA and EMA increases operational complexity as well as costs for distributors. This, in turn, may negatively impact the healthcare distribution market growth during the forecast period. Global supply chain disruptions due to geopolitical conflicts, pandemics, and natural disasters are delaying product availability and distribution. These disruptions create bottlenecks that impact timely delivery of critical healthcare products, posing a substantial barrier to seamless market expansion. Rapid Expansion of Healthcare Infrastructure Creating Lucrative Growth Opportunities Nations like China, India, and Brazil are heavily investing in healthcare infrastructure like hospitals, diagnostic centers, and clinics. This growing network of medical facilities requires efficient and reliable distribution of pharmaceuticals and medical devices, thereby creating strong growth opportunities for healthcare distribution companies. Impact of AI on the Healthcare Distribution Market Artificial Intelligence (AI) is becoming a transformative force in the healthcare distribution market. It drives greater efficiency, accuracy, and responsiveness across the supply chain. AI-powered systems enable predictive analytics for inventory management, thereby reducing waste and ensuring timely delivery of critical medical supplies. Similarly, AI enhances decision-making by identifying demand patterns as well as optimizing logistics routes. AI is streamlining processes from warehouse operations to last-mile delivery. By doing so, it contributes to a more resilient and responsive healthcare distribution network. Emerging Healthcare Distribution Market Trends Growing demand for biologics and specialty drugs is significantly influencing the healthcare distribution landscape. These products often require temperature-controlled storage and transport conditions, fueling innovation and increased investment in cold chain logistics and advanced supply chain infrastructure. Rise of digital health platforms and e-pharmacies is fueling demand for streamlined, technology-driven distribution models. With modern consumers increasingly preferring doorstep delivery of medications, healthcare distributors are being pushed to innovate and enhance their logistics infrastructure. Technological advancements like AI, automation, blockchain, and IoT are transforming the healthcare distribution industry. These innovations enhance supply chain visibility, optimize inventory management, and help reduce operational costs, contributing to overall market growth. Rising environmental concerns are prompting companies to adopt sustainable packaging and fuel-efficient transportation. For instance, in March 2024, DKSH Healthcare Thailand launched the first dedicated electric vehicle for healthcare distribution in Thailand. Request for Customization: Analyst's View said senior analyst Manisha Vibhute. Current Events and Their Impact on the Healthcare Distribution Market Event Description and Impact Global Drug Shortages & Supply Chain Diversification (2024–2025) Description: Ongoing global drug shortages, especially in generics and injectables, due to geopolitical tensions (e.g., Red Sea shipping crisis) and manufacturing constraints. Impact: Distributors are investing in multi-source procurement, domestic manufacturing partnerships, and buffer stock models to ensure continuity and mitigate dependence on any single region. AI and Predictive Logistics in Post-COVID Healthcare Systems Description: The pandemic accelerated the adoption of AI in healthcare logistics to optimize inventory, forecast demand, and reduce waste. Impact: Distributors are using AI to reduce stockouts and proactively manage demand surges for critical care items. Sustainability Pressures & Green Logistics Initiatives Description: Healthcare distributors face growing pressure to reduce environmental impact amid tightening ESG regulations (e.g., proposed Scope 3 emission disclosures by the U.S. SEC, EU sustainability directives). Impact: Companies are adopting electric vehicle (EV) fleets, enhancing energy efficiency in cold chains, and partnering with carbon-neutral or LEED-certified warehouse providers to meet stakeholder sustainability goals. Competitor Insights Key companies in healthcare distribution market report include: McKesson Corporation AmerisourceBergen Corporation Cardinal Health, Inc. Medline Industries Shanghai Pharmaceutical Group Co., Ltd. Henry Schein Inc. Medline Industries PHOENIX Group Owens & Minor, Inc. FFF Enterprises, Inc. Rochester Drug Cooperative, Inc. Dakota Drug, Inc. Shields Health Solutions Mutual Drug Company Consorta, Inc. Value Drug Company Key Developments In March 2025, Entero Healthcare Solutions Limited launched the 'HealthEdge' programme for retail chemists. This initiative is intended to accelerate digital transformation of retail chemists, equipping them with advanced tools to improve business efficiency, profitability, and customer engagement. In October 2024, McKesson introduced InspiroGene by McKesson, a specialized division focused on facilitating the commercialization of cell and gene therapies (CGTs). The entity's mission is indeed to assist manufacturers, payers, and providers in navigating the complex CGT commercial landscape. Market Segmentation: By Product Type Pharmaceutical Product Distribution Services Over The Counter Drugs Generic Drugs Branded Drugs Biopharmaceutical Product Distribution Service Recombinant Proteins Monoclonal Antibodies Blood Products Vaccines Medical Devices Distribution Services By End User Hospital Pharmacies Retail Pharmacies Online Pharmacies Others By Region North America Europe Asia Pacific Latin America Middle East Africa Read Related Reports: Smart Healthcare Market Size, Share & Trend Analysis Report for 2025-2032Mail Order Pharmacy Market Analysis and Forecast for 2025-2032Home Healthcare Market Size, Share, Trends & Opportunities for 2025-2032 Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News: CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights Pvt. Ltd, U.S.: + 12524771362 U.K.: +442039578553 AUS: +61-2-4786-0457 INDIA: +91-848-285-0837 Email: sales@ For Latest Update Follow Us: LinkedIn | Facebook | TwitterError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
Robotic Surgery Market 2025 Trends: Advanced AI Systems, Telesurgery and $400M Investments Power Global Expansion
The global robotic surgery market size is calculated at USD 13.79 billion in 2025 and is expected to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% for the forecasted period. Ottawa, July 03, 2025 (GLOBE NEWSWIRE) -- The global robotic surgery market size was valued at USD 11.83 billion in 2024 and is predicted to hit around USD 54.66 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The growing and expanding research and development in the healthcare sector and growing support by the government for innovation in technology drive the growth of the market. Get a sneak peek into key trends and data shaping the robotic surgery market: Key Highlights North America led the robotic surgery market in 2024. Asia Pacific is estimated to grow at the fastest rate in the market during the forecast period. By offering, the products segment held the largest share of the market in 2024. By offering, the services segment is estimated to grow at the fastest rate in the market during the forecast period. By applications, the orthopedics segment was dominant in the robotic surgery market in 2024. By applications, the general surgery segment is projected to grow at the fastest CAGR during the predicted timeframe. By end-user, the hospitals segment registered its dominance over the global market in 2024. By end-user, the ambulatory surgical centers segment is expected to witness the fastest growth in the market over the coming years. Market Overview & Potential The robotics surgery is carried out by the robotics system with the assistance of the surgeons to minimize errors. These surgeries help in minimizing invasive procedures, along with ensuring enhanced precision and dexterity. Robotics consists of arms which is assisted and controlled by the surgeon with the help of a high-definition camera, which ensures to offer a three-dimensional view of the surgical site. They are applied in various surgical specialties like urology, general surgery, cardiothoracic surgery, and gynaecology. The key aspects associated with robotics surgery are minimal invasion, enhanced precision and control, improved visualization, and versatile applications. The key growth drivers responsible for the growth of the market are the increasing demand for minimally invasive procedures due to patient preference and surgeon preference for better robotic systems, technological advancements like integration of AI, advanced visualization, and enhanced robotics surgical systems, which fuel the growth of the market. There is increasing demand due to the improved outcomes and reduced complications associated which results in higher success rates and reduced human error which leading to more accurate and precise surgical procedures, which contributes to the growth of the market, resulting in the expansion of the robotic surgery market globally. Access comprehensive market figures, forecasts, and segment-wise breakdowns in one place: What Are the Growing Trends Associated with The Robotic Surgery Market? Technological Advancements Technological advancement and innovation in robotic techniques, like improvement in robotic systems and enhancement in surgical methods, are a growing trend in the market. Increasing Prevalence of Diseases The increasing prevalence of diseases in an aging population fuels the demand for advanced and precise surgical techniques, with robotic assistance driving the growth of the market. Enhanced Precision Robotics enhances precision in surgery and also helps in complex performances with faster recovery and fewer incisions, which attracts researchers, which fuels the growth of the market. Demand for Automation The need and demand for automation in medical science is a growing trend that contributes to the growth of the market. What Is the Growing Challenge in The Robotic Surgery Market? The high cost of the robotics system and process is a challenge to the growth of the market. The challenging and complex procedure for the precise and accurate surgery requires high-end and advanced research and systems, which demand high investments and operational costs, which limit the growth of the market. The large labour cost, maintenance cost, and operational costs are the challenges that limit growth. This factor hinders the adoption and growth of the market. You can place an order or ask any questions, please feel free to contact us at sales@ Regional How Did North America Dominate the Robotic Surgery Market In 2024? North America dominated the robotics surgery market in 2024, and the growth is driven by the growing benefits offered due to advanced healthcare infrastructure in the region, which plays a significant role in the growth of the market. The development is associated with significant investments in research and development in the public as well as private sectors, which fuels the growth of the market in the region. How Is the US Leading the Robotics Surgery Market? The US has seen a significant growth in the robotics surgery market, and the growth of the market is driven by the increasing awareness in the country regarding the benefits of robotics surgery, like reduced invasiveness, improved outcomes, precision, and faster recovery. These advancements boost the growth of the market in the country. Technological advancements and the presence of trained and skilled medical practitioners in the country also play a significant role in the growth and expansion of the market in the country. According to Volza's United States Export data, the United States shipped out 42 Robotic Systems shipments from September 2023 to October 2024 (TTM). These exports were handled by 24 United States exporters to 13 buyers, showing a growth rate of 35% over the previous 12 months. According to Volza's Export data, globally, Mexico, China, and Germany are the top three exporters of Robotic Systems. Mexico is the global leader in Robotic Systems exports with 22,160 shipments, followed closely by China with 3,134 shipments, and Germany in third place with 1,851 shipments. Get the latest insights on healthcare industry segmentation with our Annual Membership: What Made Asia Pacific Significantly Grow in the Robotic Surgery Market In 2024? Asia Pacific has seen significant growth in the robotic surgery market; the growth is driven by the increasing healthcare investments by the government and the promotion and development of robotics-assisted surgeries in the public and private healthcare facilities in the region. The growing adoption of robotic surgeries by hospitals due to their precision and accuracy fuels the growth of the market. The growth in the Indian market is driven by the private sector expansion and growing demand due to its benefits and offerings, which boost the growth. According to Volza's India Export data, India shipped out 3.3K Robotic Systems shipments. These exports were handled by 238 indian exporters to 198 buyers. How common is robotic surgery in India? The robotic surgery market has seen steady growth in India. The growing use of robots in performing complicated surgeries for minimal invasion and precision. This growth is driven by the increasing demand for minimally invasive procedures, Technological advancements, and the growing prevalence of chronic diseases in the country, which fuels the growth of the market in the country. Technological advancements like the integration of AI, machine learning, and miniaturization help in enhancing the precision demanded by the market in the country. The governmental support and initiatives for the adoption of robotics surgery in hospitals also support the growth of the market in the country. This places the nation almost on a par with developed countries, said Ajay Narasimhan, senior consultant at the department of minimally invasive and robotic thoracic surgery at Apollo Hospitals, Chennai. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes schedule a call today: Segmental Insights By Offerings The products segment dominated the robotic surgery market in 2024. The growth of the market is driven by the growing demand for advanced systems and sophisticated robotic surgery systems, along with advanced technologies, which increases the demand for the market. The growing demand from hospitals and healthcare providers for robotic surgery technology to enhance and improve the surgical accuracy and outcomes fuels the growth of the market. The growing adoption by specialty sectors or departments like gynecology, urology, and orthopedics increases the demand for the goods, boosting the growth of the market and contributing to the expansion globally. The services segment expects the fastest growth in the robotic surgery market during the forecast period. The growth of the market is driven by the growing investments by the government and private sectors in the training and software developments for delivering comprehensive and effective solutions fuels the growth of the market. The improvement and enhancement in the longevity and effectiveness of the robotics system drive the demand for advanced services to ensure accuracy and accurate procedures and operations, which boosts the growth of the market. Patient compliance, along with professional compliance, is a major factor for effective services and solutions driving the growth of the market. By Application The orthopedics segment dominated the robotic surgery market in 2024. The growth of the market of driven by the significant use and adoption of robotic surgery for performing procedures on the musculoskeletal system, fueling the growth. They are generally used in knee and hip replacements, spinal surgeries, and fracture repairs due to their potential benefits, like faster recovery, improved accuracy, and reduced pain, which boosts the growth of the market. The 3D imaging and navigation allow surgeons to precisely site and visualize the site accurately for improved outcomes and perform the method with greater accuracy, which helps boost the growth of the market. The general surgery segment is expected fastest growth in the robotic surgery market during the forecast period. The growing demand for accurate and well-optimized procedures for minimally invasive surgical techniques to enhance precision, flexibility, offering, controlled method, and offering of benefits like smaller invasion, faster recovery, and less pain are key factors that help in the growth of the market. The areas where it is used are hernia repair, gallbladder removal, and gastrointestinal surgeries, which boosts the demand for the market and helps in expansion. By End Use The hospitals segment dominated the robotic surgery market in 2024. The growth os the market is driven by the benefits offered with robotics surgery, like surgeon control, enhanced visualization, and minimal invasion, which helps in the growing demand for the advanced equipment, extensive infrastructure, which fuels the growth. The growing chronic diseases and injuries of trauma, leading to and demand for complex surgical procedures, require a precise and accurate control system, which increases the demand for robotic surgical procedures which driving the growth of the market. Growing adoption of advanced surgical interventions and precision with shorter recovery timelines from the surgeons for the patients boosts the growth and supports the expansion of the market globally. The ambulatory surgical centers segment is expected to experience the fastest growth in the robotic surgery market during the forecast period. The specialty offered, like cost effectiveness and efficient procedure for surgery with minimal invasion, drives the growth. The growing demand for reduced recovery time, minimized complications, and precision is the key that fuels the growth of the market. The key aspects responsible for the growth are the outpatient's focus, cost effectiveness, convenience, and quality care, ensuring patient safety boosts the growth of the market and supports expansion. Top 10 Companies in the Market and Their Contributions Company Notable System(s) Contributions Intuitive Surgical da Vinci 5, Xi, SP Global leader with >8,600 units; pioneers multi-port platforms with force-sensing, 3D HD visuals, aiding millions in urology, gynecology, and general surgery Stryker Mako SMARTRobotics Robotics for ortho: joint replacements (hip, knee), now expanding to spine/shoulder; high installation rate improving precision Medtronic Hugo RAS, Mazor X Modular, cloud-connected RAS platform for urology, soft-tissue, and spine robot with analytics Johnson & Johnson Ottava by Ethicon, Velys Integrates existing instruments in flexible multi-arm RAS; Velys aids knee replacements Smith & Nephew Cori, Navio Portable, cost-effective orthopedic robots with AI-driven pre-op planning Zimmer Biomet ROSA, TMINI Robotic platforms for knee, hip, shoulder; distribution tie-up for miniature TMINI CMR Surgical Versius Modular, portable RAS with FDA clearance; easier setup and workflow flexibility Asensus Surgical Senhance Robotic laparoscopy with haptic feedback, eye-tracking, and AI-augmented workflows. Renishaw neuromate High-precision stereotactic robot for neurosurgery and image-guided interventions. Globus Medical ExcelsiusGPS Spine-focused robot integrating navigation, sub-mm accuracy for screw placement. Recent Developments In January 2025, Prashanth Hospitals launched the Institute of Robotic Surgery and a surgical robotic system for minimally invasive surgeries. Robotic surgery gives patients the advantage of early recovery, less pain, less blood loss, and reduced incisions, and added that the hospital launched an indigenously developed robot. In March 2025, IPGMER launched its first robotic surgery to boost the healthcare department. The hospital planned to use the technology to perform general surgery, urology, and gynaecology. Robotics can be used in multi-disciplinary surgical procedures. This is a great innovation in the field of medical technology. In December 2024, A made-in-India surgical robot was installed in Pune's Noble Hospitals and Research Centre. The SSI Mantra surgical robot, which recently received approval from the Central Drugs Standard Control Organisation (CDSCO), India's regulatory body, is a 3-robotic system for performing intricate surgeries. Browse More Insights of Towards Healthcare: 1. NLP in Healthcare and Life Sciences MarketThe global market for natural language processing (NLP) in healthcare and life sciences is growing fast. It was worth $6.66 billion in 2024, rose to $8.97 billion in 2025, and is expected to reach $132.34 billion by 2034. It's growing at a strong annual rate of 34.74%. 2. E-Prescription MarketThe e-prescription market is also expanding quickly. It was $4.71 billion in 2024, increased to $5.97 billion in 2025, and is expected to reach $53.17 billion by 2034. The market is growing at a yearly rate of 26.84%. 3. AI & ML in Drug Development MarketThe use of artificial intelligence (AI) and machine learning (ML) in drug development is growing worldwide. From 2025 to 2034, this market is expected to generate hundreds of millions in revenue, driven by more investment, innovation, and growing demand. 4. Pharmacy Automation MarketThe pharmacy automation market was valued at $6.35 billion in 2024 and grew to $6.99 billion in 2025. It's expected to reach $16.65 billion by 2034, growing at 10.12% annually. This growth is due to better technology and the need for improved patient care. 5. Continuous Manufacturing Systems MarketThis continuous manufacturing systems market was worth $689.15 million in 2024 and will grow to $772.13 million in 2025. By 2034, it's expected to reach $2.15 billion, with a yearly growth rate of 12.04%. Continuous systems help improve production efficiency in healthcare. 6. AI in Healthcare Revenue Cycle Management MarketThis AI in healthcare revenue cycle management market was valued at $20.68 billion in 2024 and will rise to $25.7 billion in 2025. It's expected to reach $180.33 billion by 2034, growing at 24.2% annually. AI is helping healthcare organizations manage their billing and financial processes more efficiently. 7. AI in Mass Spectrometry Software MarketThe AI in mass spectrometry software market is growing strongly. From 2025 to 2034, it's expected to generate hundreds of millions in revenue due to increasing demand and new trends in data analysis and diagnostics. 8. AI-Powered Claim Denial Management MarketThis AI-powered claim denial management market is also seeing major growth. Between 2025 and 2034, revenue is expected to rise significantly as healthcare providers use AI to handle denied insurance claims more effectively. 9. AI in Medical Billing MarketThe AI in medical billing market was $3.73 billion in 2024 and grew to $4.68 billion in 2025. It's expected to reach $36.37 billion by 2034, growing at a strong rate of 25.4% per year. AI helps speed up and simplify the billing process. 10. Digital Healthcare Education MarketThe digital healthcare education market was valued at $53.67 billion in 2024 and increased to $58.2 billion in 2025. By 2034, it's projected to reach $120.67 billion, growing at 8.44% annually. More healthcare professionals are turning to digital learning tools and platforms. Key players list in Robotic Surgery Market Smith & Nephew Medrobotics Corporation TransEnterix Surgical, Inc. Intuitive Surgical Renishaw Plc Stryker Corporation THINK Surgical, Inc. Zimmer Biomet Medtronic Plc CMR Surgical Segments Covered in the Report By Offering Products Robotics System Laparoscopic Robotic System Orthopedic Robotic System Neurosurgical Robotic System Other Robotic systems Services By Applications Orthopedics Neurology Urology Gynecology General Surgery Others By End-User Hospitals Ambulatory Surgical Centers Other By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Unlock the complete analysis with expert insights, market drivers and competitive intelligence: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us:
Yahoo
44 minutes ago
- Yahoo
ParaZero Receives a Recurring Bulk Order of SafeAir Systems from an Australian Distributor
Kfar Saba, Israel, July 03, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the 'company' or 'ParaZero'), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems today announced that it has received a follow-on order for its SafeAir™ drone safety systems from a leading Australian drone technology distributor. This new order specifically includes SafeAir™ systems for widely deployed DJI platforms across various commercial, law enforcement, search and rescue and other governmental sectors. This order follows the distributor's initial procurement in late 2024, which marked ParaZero's growing presence in the Australian market. The distributor continues to expand its offering of CASA-recognized SafeAir systems to meet increasing demand driven by evolving drone regulations and the need for safety-assured operations. ParaZero's SafeAir system is designed to autonomously detect flight anomalies and deploy a parachute in the event of failure, significantly reducing the risk of injury or damage. Operational safety credit granted by Civil Aviation Safety Authority (CASA) to operators specifically using the SafeAir System have made it a key enabler for commercial drone flights over or near people and populated areas across Australia. 'This follow-on order highlights the continued trust our partners place in ParaZero's safety technologies,' said Boaz Shetzer, CEO of ParaZero. 'The adoption of SafeAir for DJI's drones reflects the industry's growing focus on regulatory compliance and operational safety, especially for widely-used drone platforms.' About ParaZero Technologies ParaZero (Nasdaq: PRZO) is an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems. Started in 2014 by a passionate group of aviation professionals and drone industry veterans, ParaZero designs smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond-visual-line-of-sight (BVLOS) as well as for various military applications including Counter UAS. For more information about ParaZero, please visit Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as 'expects,' 'anticipates,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates' and similar expressions or variations of such words are intended to identify forward-looking statements. For example, ParaZero is using forward-looking statements when it discusses its growing presence in the Australian market, increasing demand driven by evolving drone regulations and the need for safety-assured operations and the drone industry's growing focus on regulatory compliance and operational safety, especially for widely-used drone platforms. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ('SEC'), including, but not limited to, the risks detailed in the Company's Annual Report on Form 20-F filed with the SEC on March 21, 2025. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites. Investor Relations Contact: Michal Efraty Investor Relations michal@ ParaZero Technologies Ltd. | 1st HaTachana St. Kfar Saba, Israel 4453001 P: +972-502753666 | E: contact@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
